SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-21-028301
Filing Date
2021-08-13
Accepted
2021-08-13 17:16:37
Documents
71
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10027925_10q.htm   iXBRL 10-Q 1549978
2 EXHIBIT 31.1 brhc10027925_ex31-1.htm EX-31.1 9065
3 EXHIBIT 31.2 brhc10027925_ex31-2.htm EX-31.2 8930
4 EXHIBIT 32.1 brhc10027925_ex32-1.htm EX-32.1 5637
5 EXHIBIT 32.2 brhc10027925_ex32-2.htm EX-32.2 5317
11 image00001.jpg GRAPHIC 4416
  Complete submission text file 0001140361-21-028301.txt   6748971

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA btx-20210630.xsd EX-101.SCH 63938
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE btx-20210630_cal.xml EX-101.CAL 54025
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE btx-20210630_def.xml EX-101.DEF 278059
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE btx-20210630_lab.xml EX-101.LAB 734653
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btx-20210630_pre.xml EX-101.PRE 421611
12 EXTRACTED XBRL INSTANCE DOCUMENT brhc10027925_10q_htm.xml XML 891608
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11460 | Film No.: 211173366
SIC: 2834 Pharmaceutical Preparations